“Treatment with a proton pump inhibitor improves glycaemic control in type 2 diabetic patients”., J. Dhaka Natl. Med. Coll. Hosp., vol. 28, no. 1, pp. 42–45, Mar. 2022, doi: 10.3329/jdnmch.v28i1.80681.